This paper reports the determination of trace levels of 5 types of fluorinated quinolone drugs, i.e., ciprofloxacin, norfloxacin, enoxacin, pefloxacin, and ofloxacin, by thin-layer chromatography (TLC)/fluorescence densitometry. The new analytical method uses 2-step TLC development, selective separation, and simultaneous determination of the 5 drugs. The method was also applied to the determination of recoveries of standards of the 5 drugs in plasma and urine samples. The results show that the method has a wide linear range, high repeatability, and good stability. F luorinated quinolone drugs-ciprofloxacin (CPLX), norfloxacin (NFLX), enoxacin (ENX), pefloxacin (PFLX), and ofloxacin (OFLX)-are a type of broad-spectrum bacteriophage and have been widely used for curing various infections caused by Gram-positive and -negative bacteria. Their characteristics are a high biological utilization ratio, low toxicity, few side effects, and low drug resistance (1), as well as easy formation of chelates with transition metal ions (2). Analytical methods reported for these compounds have used spectrophotometry (3, 4), liquid chromatography (5, 6), and electrochemistry (7, 8) . However, the selective separation and simultaneous determination of these 5 drugs at trace levels in body fluids by thin-layer chromatography (TLC)/fluorescence densitometry have not been reported previously. The present method uses a newly tested technology in which trace analysis is combined with a separation procedure. It was applied to the separation and determination of the 5 drugs in plasma and urine samples. The recoveries of standards at different concentrations were measured, and the results were satisfactory. Therefore, the use of TLC/fluorescence densitometry for the simultaneous determination of the 5 drugs was established. This method is rapid, convenient, sensitive, and accurate and is especially suited to the dynamic study of drug substitution in a clinical setting. (f) Fluorinated quinolone drugs.-CPLX, NFLX, ENX, PFLX, and OFLX; all standard grade (>98% purity), purchased from Institute of Drug Test (Taiyuan, Shanxi Province, People's Republic of China).
F luorinated quinolone drugs-ciprofloxacin (CPLX), norfloxacin (NFLX), enoxacin (ENX), pefloxacin (PFLX), and ofloxacin (OFLX)-are a type of broad-spectrum bacteriophage and have been widely used for curing various infections caused by Gram-positive and -negative bacteria. Their characteristics are a high biological utilization ratio, low toxicity, few side effects, and low drug resistance (1), as well as easy formation of chelates with transition metal ions (2) . Analytical methods reported for these compounds have used spectrophotometry (3, 4) , liquid chromatography (5, 6) , and electrochemistry (7, 8) . However, the selective separation and simultaneous determination of these 5 drugs at trace levels in body fluids by thin-layer chromatography (TLC)/fluorescence densitometry have not been reported previously. The present method uses a newly tested technology in which trace analysis is combined with a separation procedure. It was applied to the separation and determination of the 5 drugs in plasma and urine samples. The recoveries of standards at different concentrations were measured, and the results were satisfactory. Therefore, the use of TLC/fluorescence densitometry for the simultaneous determination of the 5 drugs was established. This method is rapid, convenient, sensitive, and accurate and is especially suited to the dynamic study of drug substitution in a clinical setting. 
Experimental

Apparatus and Reagents
Pretreatment of Silica Gel Plates
Silica gel plates were immersed for 2-3 s in a 0.27M EDTA solution at pH 7, and then the plates were removed from the solution and placed horizontally to dry. The plates were dried for ca 2 h in air at room temperature and then activated in an oven at 105EC for 40 min. While the plates were still hot, they were placed in a desiccator for future use.
Operating Procedure
Standard solutions of CPLX, NFLX, PFLX, ENX, and OFLX at 1 mg/mL were prepared in methanol-dichloromethane (1 + 1, v/v).
A mixed standard solution was prepared by adding 0.3 mL of each of the above standard solutions to a 5 mL volumetric flask and diluted to volume with methanol. The final solution contained each standard at 0.06 mg/mL.
A pretreated TLC plate was marked gently with a clean pinhead ca 1 cm from the bottom of the plate, and 0.5 µL mixed standard solution or sample solution was applied to the plate at the marked position with a sample applicator. Then the plate was dried at 105EC under an infrared lamp for 1 min. The optimized conditions for development were selected (9, 10), i.e., 10 mL chloroform was added to a clean and airtight chromatographic chamber, and the TLC plate on which the sample was deposited was placed in the chamber while the plate was equilibrated with chloroform steam for 10 min (not soaked with chloroform) so as to avoid marginal and tailing effects. The first-step developer was chloroform-methanol-toluene-dichloromethane-strong aqueous ammonia (3.5 + 6 + 2.3 + 0.7 + 0.6, v/v). The treated plate was at once transferred to the chromatographic chamber containing the first-step developer for vertical development. The developing distance was 90 mm. The developed plate was removed from the chamber and dried under an infrared lamp for 2 min. The second-step developer was chloroform-methanol-toluenedichloromethane-tetrahydrofuran-diethyl ether-n-hexanestrong aqueous ammonia (3.5 + 6 + 2.3 + 0.7 + 2 + 0.6 + 0.6 + 0.6, v/v ). The development was performed in the same manner as before, and the developing distance was again 90 mm. The developed plate was removed from the chamber. After the solvents were volatilized, 5 blue spots were observed under a UV lamp at 254 nm. These spots were not tailing and had a blue fluorescence of high intensity. The spots were round and ca 3 mm in diameter. The R f values measured for CPLX, NFLX, ENX, PFLX, and OFLX were 0.40, 0.51, 0.60, 0.72, and 0.78, respectively. The developed plates were scanned and measured with the TLC densitometer in the fluorescence mode. The resulting chromatogram is shown in Figure 1 .
The main parameters for fluorescence-scanning densitometry were as follows: reflection linear scanning; a xenon lamp as a lamp-house; high sensitivity; steplength, )Y = 0.02; least width of peak, 2.0; least area of peak, 200; data smoothing, 11 points; data accumulation, 4; 8 ex 280 and 335 nm; cutoff filter, No. 2 (495 nm).
Results and Discussion
Pretreatment of the Silica Gel Plate
Many experiments have indicated that if a mixture of the 5 compounds was applied to a silica gel plate that was not modified with EDTA, and the plate was developed, severe tailing would result, preventing effective separation. Because the fluorinated quinolone drugs could easily form chelates with transition metal ions on the plate, it might be difficult to separate the 5 compounds. In our work, we considered the influence that pretreatment of plates with EDTA solution might have on the separation of the 5 compounds. Our results showed that the pretreatment was able to prevent the formation of chelates and consequently improve the quality of the separation to a great extent. Many experiments were performed with different EDTA concentrations and pH values to determine the influence of pretreatment on the separation. The results showed that plates pretreated for 24 h with 0.27M EDTA solution at pH 7 produced optimum separation of the 5 compounds. 
Selection of Developer
The developers were selected by the Giajch triangle optimization method and the solvent parameter method (11) . First, various 5-component developing systems in different proportions were examined for their effects on the separation. Many experimental results showed that these systems could achieve satisfactory separation only for 3 compounds-CPLX, NFLX, and ENX-but not for PFLX and OFLX. Next, we grouped the solvents on the basis of selectivity (11) . The second-step developing system was obtained by adding 3 more solvents to the first-step developing system and simultaneously using the optimization method. Consequently, the efficient separation of the 5 compounds was achieved, as shown in Figure 1 . Selection of Excitation Wavelength and Emission Filter. The standard solutions of CPLX, NFLX, ENX, PFLX, and OFLX were applied to the same silica gel plate. With filter No. 2, the fluorescence intensities of the 5 compounds were measured at various excitation wavelengths. Maximum fluorescence intensities were obtained for CPLX, NFLX, and PFLX
2) at 495 nm was selected on the basis of the selection rules for emission filters (7). The cutoff filter allows the fluorescence of the sample to pass through, but it cuts off low background fluorescence in the excited light.
Repeatability
A mixed solution of CPLX, NFLX, ENX, PFLX, and OFLX was applied to 5 plates according to the operating procedure. On each plate were 10 applications of the same solution; the concentration of each compound was 30 ng/application. The space between 2 spots was 9 mm. After development, the plates were scanned, and the areas of the peaks for each spot were measured as described above. Nonuniformity in the thickness of the plates and in the granularity of the silica gel could result in different measurements for different plates; nonuniformity in the granularity of the silica gel could also affect measurements for the same plate. Errors in application and instability of the instrument could also lead to measurement error. Table 1 lists the relative standard deviations (RSD) of the measurements for different plates, the same plates, and the same plate and the same spot. The results show that the error for different plates is larger than that for the same plate, and that the error caused by the instability of the instrument is very small. Thus, in the quantitative method described in this paper, a standard solution and a sample solution are applied to the same plate.
Calibration Curves and Analytical Characteristics
A series of standard solutions of CPLX, NFLX, ENX, PFLX, and OFLX were prepared at 10 different concentrations (ranging from 0.5 to 300 ng/spot). Each of the drugs at different concentrations was applied to the same plate, the plate was developed, and the drug was determined according to the method. The cali- bration curves were prepared by plotting integrated areas on the y axis versus concentrations on the x axis. All calibration curves were straight lines through the origin. The analytical characteristics of the 5 drugs are summarized in Table 2 .
Recovery of Standards from Plasma and Urine
Proteins in plasma serum were precipitated with absolute ethanol and centrifuged for 15 min (3000 rpm). The clear solution was taken as a blank plasma sample. Aliquots of 1 mg/mL standard solutions were diluted to volume with the blank plasma sample in 10 mL graduated bottles. The aliquots for CPLX, PFLX, and NFLX were 0.01, 0.04, and 0.06 mL; those for ENX were 0.02, 0.04, and 0.06 mL; and those for OFLX were 0.01, 0.03, and 0.05 mL. Equal 0.5 µL aliquots of the fortified plasma samples, prepared as recovery solutions, and standard solutions of the 5 compounds were applied to the same TLC plates and developed as described in the method. The plates were scanned, and the levels of the 5 drugs were determined. For each plasma sample at a specific concentration, 5 parallel plates were prepared, developed, and measured. The results are shown in Table 3 .
Fresh liquid urine does not need pretreatment and is used directly as a blank urine sample. Aliquots of 1 mg/mL standard solutions were diluted to volume with the blank urine sample in 10 mL volumetric flasks. The aliquots for CPLX, PFLX, and NFLX were 0.01, 0.04, and 0.07 mL; those for ENX were 0.02, 0.04, and 0.06 mL; and those for OFLX were 0.01, 0.03, and 0.05 mL. Equal 0.5 µL aliquots of the fortified urine samples, prepared as recovery solutions, and standard solutions of the 5 compounds were applied to the same TLC plates and developed as described in the method. The plates were scanned, and the levels of the 5 drugs were determined. For each urine sample at a specific concentration, 5 parallel plates were prepared, developed, and measured. The results are shown in Table 4 .
Stability Experiment
The reliability of the experimental data depends on the stability of the 5 compounds. After application of the standard solutions and plate development, the spots were continuously scanned. A plot of their integrated areas versus time is shown in Figure 2 changes for over about 6 h. These stability results satisfy the demands of the determinations.
Analysis of Blood and Urine Samples
Drug levels in body fluids were determined with the use of an external standard. Two healthy people had taken oral doses of 500 mg CPLX and NFLX in the morning on an empty stomach. After 4-6 h, samples of their blood and urine were collected. The blood was treated as described above. The test samples and standard solutions of CPLX and NFLX were applied to the same TLC plate. After development of the plate, the levels of CPLX and NFLX in the samples were determined by scanning with the densitometer. Five applications and determinations were performed in parallel. The results are shown in Table 5 .
Conclusions
A large volume of experimental data, including the results reported here for the simultaneous determination of trace levels of 5 fluorinated quinolone drugs, indicates that TLC/fluorescence densitometry could be a highly feasible and practical technique for monitoring drug levels in blood and urine. It could also be applied to the dynamic study of drug substitution and could supply the theoretical basis for reasonable use of drugs in a clinical setting. a Collected 4-6 hr after administration of oral doses of 500 mg CPLX and NFLX.
